Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2002 Mar 1;79(1):113–127. doi: 10.1093/jurban/79.1.113

Characteristics of injection drug users who utilize tuberculosis services at sites of the baltimore city needle exchange program

Elise D Riley 1, David Vlahov 2,3, Steven Huettner 2, Peter Beilenson 4, Margaret Bonds 2, Richard E Chaisson 2,5,✉
PMCID: PMC3456382  PMID: 11937620

Abstract

Objective

To describe characteristics of needle-exchange program (NEP) participants who utilized tuberculosis services from an NEP site.

Methods

Between June 1998 and May 1999, tuberculosis services were advertised and offered to Baltimore, Maryland, NEP participants. Demographic and tuberculosis-specific data were collected on participants who self-selected into services. Analyses were based on being tuberculin skin tested, returning for a skin test reading, and testing tuberculin positive.

Results

Among 691 contacts with NEP participants, this service performed 296 tuberculin tests, with an 84% return rate for skin test reading. Participants were 32% female, 87% African American, and 11% employed. Higher frequency of NEP visits was positively associated with requesting tuberculosis services and returning for skin test reading. Among those who returned for skin test reading, longer smoking duration and problems getting food in the past year due to a lack of money were associated with a positive test.

Conclusions

Utilization of a tuberculosis service and high return rates can be achieved among NEP participants without formal recruitment strategies. Frequent exchange appears to facilitate return visits for NEP-based tuberculosis screening, which may imply accessibility for frequent exchangers. More extensive health services at sites of the Baltimore NEP appear to be warranted, with particular attention paid to effectiveness for frequent exchangers.

Keywords: Injection Drug Use, Needle-Exchange Program, Tuberculosis Prevention

Full Text

The Full Text of this article is available as a PDF (95.4 KB).

References

  • 1.Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA. 1995;274:945–951. doi: 10.1001/jama.1995.03530120037038. [DOI] [PubMed] [Google Scholar]
  • 2.Galai N, Graham N, Chaisson R, Nelson KE, Vlahov D, Lewis J. Multidrug-resistant tuberculosis. N Engl J Med. 1992;327:1172–1173. doi: 10.1056/NEJM199210153271614. [DOI] [PubMed] [Google Scholar]
  • 3.Graham NM, Galai N, Nelson KE, et al. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med. 1996;156:889–894. doi: 10.1001/archinte.1996.00440080089010. [DOI] [PubMed] [Google Scholar]
  • 4.Bishai WR, Graham NM, Harrington S, et al. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA. 1998;280:1679–1684. doi: 10.1001/jama.280.19.1679. [DOI] [PubMed] [Google Scholar]
  • 5.Perlman DC, Perkins MP, Solomon N, Kochems L, Des Jarlais DC, Paone D. Tuberculosis screening at a syringe exchange program. Am J Public Health. 1997;87:862–863. [PubMed] [Google Scholar]
  • 6.Salomon N, Perlman DC, Perkins MP, et al. Knowledge of tuberculosis among drug users: relationship to screening return rates. J Subst Abuse Treat. 1999;16:229–235. doi: 10.1016/S0740-5472(98)00033-6. [DOI] [PubMed] [Google Scholar]
  • 7.Platt J. Heroin Addiction Theory, Research and Treatment. 2nd ed. Malabar, FL: Robert E Krieger Publishing Co.; 1986. pp. 221–221. [Google Scholar]
  • 8.Riley E, Vlahov D, Safrahein M, Junge B, Beilenson P, Strathdee S. Gender differences in drug use patterns and successful referrals to drug treatment among Baltimore needle exchange participants. Paper presented at: Annual Meeting of the College on Problems of Drug Dependence; June 13–17, 1999; Acapulco, Mexico.
  • 9.Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health. 1991;81:1285–1290. doi: 10.2105/AJPH.81.10.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hunter RVM, Rios E, Gomez MA. Persistent intravenous drug abuse and health encounters. Natl Conf Hum Retroviruses Relat Infect. 1995;2:165–165. [Google Scholar]
  • 11.Nelson KE, Vlahov D, Solomon L, Cohn S, Munoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Maryland. Arch Intern Med. 1995;155:1305–1311. doi: 10.1001/archinte.1995.00430120091011. [DOI] [PubMed] [Google Scholar]
  • 12.Jimenez AD, Johnson WA, Hershow RC, Wiebel WW, Rahimian A. Behavioral and sociocultural factors related to variations in TB treatment compliance among IDUs: an ethnographic study. Paper presented at: Annual Meeting of the American Public Health Association; November 17–21, 1996; New York, New York.
  • 13.Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:400–406. doi: 10.1097/00042560-199712150-00014. [DOI] [PubMed] [Google Scholar]
  • 14.Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD. Effects of an incentive and education programon return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:455–459. doi: 10.1097/00042560-199604150-00005. [DOI] [PubMed] [Google Scholar]
  • 15.Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health. 1998;88:792–796. doi: 10.2105/AJPH.88.5.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Malotte CK, Hollingshead JR, Rhodes F. Monetary versus nonmonetary incentives for TB skin test reading among drug users. Am J Prev Med. 1999;16:182–188. doi: 10.1016/S0749-3797(98)00093-2. [DOI] [PubMed] [Google Scholar]
  • 17.Flynn C, Junge MB, Riley E, Cohn S, Beilenson P, Vlahov D. Selection bias in needle exchange participation as observed in two cohorts of injection drug users. Paper presented at: Twelfth World AIDS Conference; June 28–July 3, 1998; Geneva, Switzerland.
  • 18.Centers for Disease Control and Prevention Anergy skin testing and tuberculosis preventive therapy for HIV-infected persons: revised recommendations. MMWR Morb Mortal Wkly Rep. 1997;46:1–10. [PubMed] [Google Scholar]
  • 19.American Thoracic Society/Centers for Disease Control and Prevention Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221–S247. doi: 10.1164/ajrccm.161.supplement_3.ats600. [DOI] [PubMed] [Google Scholar]
  • 20.Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75–100. [PubMed] [Google Scholar]
  • 21.O’Connor PG, Selwyn PA, Schottenfeld RS. Medical care for injection-drug users with human immunodeficiency virus infection [see comments] N Engl J Med. 1994;331:450–459. doi: 10.1056/NEJM199408183310707. [DOI] [PubMed] [Google Scholar]
  • 22.Graham NM, Nelson KE, Solomon L, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and-seronegative intravenous drug users. JAMA. 1992;267:369–373. doi: 10.1001/jama.1992.03480030047035. [DOI] [PubMed] [Google Scholar]
  • 23.Robert CF, Hirschel B, Rochat T, Deglon JJ. Tuberculin skin reactivity in HIV-seropositive intravenous drug addicts. N Engl J Med. 1989;321:1268–1268. doi: 10.1056/nejm198911023211812. [DOI] [PubMed] [Google Scholar]
  • 24.Stoneburner RL, Des Jarlais DC, Benezra D, et al. A larger spectrumof severe HIV-1-related disease in intravenous drug users in New York City. Science. 1988;242:916–919. doi: 10.1126/science.3187532. [DOI] [PubMed] [Google Scholar]
  • 25.Selik RM, Starcher ET, Curran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS. 1987;1:175–182. [PubMed] [Google Scholar]
  • 26.Rieder HL, Cauthen GM, Comstock GW, Snider DE., Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989;11:79–98. doi: 10.1093/oxfordjournals.epirev.a036046. [DOI] [PubMed] [Google Scholar]
  • 27.Centers for Disease Control and Prevention Prevention and control of tuberculosis in US communities with at-risk minority populations, and prevention and control of tuberculosis among homeless persons: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;41:1–21. [PubMed] [Google Scholar]
  • 28.Burwen DR, Bloch AB, Griffin LD, Ciesielski CA, Stern HA, Onorato IM. National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome. Arch Intern Med. 1995;155:1281–1286. doi: 10.1001/archinte.1995.00430120062008. [DOI] [PubMed] [Google Scholar]
  • 29.Tashkin DP, Khalsa ME, Gorelick D, Chang P, Simmons MS, Coulson AH, Gong H., Jr. Pulmonary status of habitual cocaine smokers. am Rev Respir Dis. 1992;145:92–100. doi: 10.1164/ajrccm/145.1.92. [DOI] [PubMed] [Google Scholar]
  • 30.Perper JA, Van Thiel DH. Respiratory complications of cocaine abuse. Recent Dev Alcohol. 1992;10:363–377. doi: 10.1007/978-1-4899-1648-8_18. [DOI] [PubMed] [Google Scholar]
  • 31.Warner EA. Is your patient using cocaine? Clinical signs that should raise suspicion. Postgrad Med. 1995;98:173–176. doi: 10.1080/00325481.1995.11946036. [DOI] [PubMed] [Google Scholar]
  • 32.Markowitz N, Hansen NI, Wilcosky TC, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med. 1993;119:185–193. doi: 10.7326/0003-4819-119-3-199308010-00002. [DOI] [PubMed] [Google Scholar]
  • 33.Janis EM, Allen DW, Glesby MJ, et al. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Am J Med. 1996;100:186–192. doi: 10.1016/S0002-9343(97)89457-0. [DOI] [PubMed] [Google Scholar]
  • 34.Hawkins WE, Latkin C, Mandel W, Oziemkowska M. Do actions speak louder than words? Perceived peer influences on needle sharing and cleaning in a sample of injection drug users. AIDS Educ Prev. 1999;11:122–131. [PubMed] [Google Scholar]
  • 35.Latkin CA, Knowlton AR, Hoover D, Mandell W. Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study. Am J Drug Alcohol Abuse. 1999;25:463–473. doi: 10.1081/ADA-100101873. [DOI] [PubMed] [Google Scholar]
  • 36.Wiebel WW. Identifying and gaining access to hidden populations. NIDA Res Monogr. 1990;98:4–11. [PubMed] [Google Scholar]
  • 37.Adler P. Ethnographic research on hidden populations: penetrating the drug world. NIDA Res Monogr. 1990;98:96–112. [PubMed] [Google Scholar]
  • 38.Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Des Jarlais DC. Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep. 1994;109:319–327. [PMC free article] [PubMed] [Google Scholar]
  • 39.Wolfe H, Marmor M, Maslansky R, et al. Tuberculosis knowledge among New York City injection drug users. Am J Public Health. 1995;85:985–988. doi: 10.2105/AJPH.85.7.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Altice FL, Fleck EM, Selwyn PA, Kaplan EH, Barry M, Gomez J. Provision of health care and HIV counseling and testing for clients of the New Haven Needle Exchange Program (NEP). Paper presented at: Ninth International Conference on AIDS; June 7–11, 1993; Berlin, Germany.
  • 41.Altice F, Khooshnood K, Blankenship KM, Lamberti MP, Selwyn PA. Needle exchange based health services as a comprehensive community prevention program. Paper presented at: Twelfth World AIDS Conference; June 28–July 3, 1998; Geneva, Switzerland.
  • 42.Lum PJ, Guydish JR, Brown C, Allen R. An innovative needle exchange programexclusively for women is well accepted by women injection drug users in San Francisco. Paper presented at: Twelfth World AIDS Conference; 1998; Geneva, Switzerland.

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES